A severe complication of intravesical bacillus Calmette-Guerin: An effect of different strains

The use of intravesical BCG has improved the survival and outcomes in the treatment of bladder cancer. However, the worldwide shortage of OncoTice BCG has caused disruption and changes in treatment regimes, leading to use of alternative strains. We describe a severe complication as the result of usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Low, Li Sian, Scholtz, David, Leyland, John, Nair, Shiva Madhwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Inflammation and Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868797/
https://www.ncbi.nlm.nih.gov/pubmed/33598408
http://dx.doi.org/10.1016/j.eucr.2021.101592
Descripción
Sumario:The use of intravesical BCG has improved the survival and outcomes in the treatment of bladder cancer. However, the worldwide shortage of OncoTice BCG has caused disruption and changes in treatment regimes, leading to use of alternative strains. We describe a severe complication as the result of using intravesical SII Onco BCG for the treatment bladder cancer, in an 82 year old man presenting with granulomatous epididymo-orchitis.

Ejemplares similares